Dr. Hönle Forecast, price target & analysts
Dr. Hönle Target price 2025 - Analyst rating & recommendation
Dr. Hönle Classifications & Recommendation:
Dr. Hönle Price Target
| Target Price | €17.34 |
| Price | €6.96 |
| Potential |
149.14%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Dr. Hönle 2026 .
The average Dr. Hönle target price is €17.34.
This is
149.14%
register free of charge
€19.95
186.64%
register free of charge
€15.15
117.67%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Dr. Hönle to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Dr. Hönle stock has an average upside potential 2026 of
149.14%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million € | 98.73 | 96.76 |
| 7.16% | 2.00% | |
| EBITDA Margin | 4.11% | 6.33% |
| 695.08% | 53.93% | |
| Net Margin | -13.17% | -1.05% |
| 27.18% | 92.03% |
4 Analysts have issued a sales forecast Dr. Hönle 2025 . The average Dr. Hönle sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Dr. Hönle EBITDA forecast 2025. The average Dr. Hönle EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Dr. Hönle Analysts have issued a net profit forecast 2025. The average Dr. Hönle net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | -2.14 | -0.17 |
| 18.23% | 92.06% | |
| P/E | negative | |
| EV/Sales | 0.90 |
4 Analysts have issued a Dr. Hönle forecast for earnings per share. The average Dr. Hönle EPS is
This results in the following potential growth metrics and future valuations:
Current Dr. Hönle Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| NUWAYS AG |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | Dec 09 2025 |
| WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | Sep 15 2025 |
| HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | May 26 2025 |
| HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | May 25 2025 |
| WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | May 13 2025 |
| WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | May 12 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
NUWAYS AG:
Locked
➜
Locked
|
Dec 10 2025 |
|
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
Dec 09 2025 |
|
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
Sep 15 2025 |
|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
May 26 2025 |
|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
May 25 2025 |
|
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
May 12 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
